Company News
Novo Nordisk Partners OpenAI, Shares Rise 2%
Novo Nordisk announced a strategic partnership with OpenAI to embed AI across drug discovery, manufacturing, supply chain, and commercial operations.
The collaboration aims to analyze complex datasets